1. Home
  2. RIGL
  3. RIGL News

Latest Rigel Pharmaceuticals Inc. (RIGL) News on July 9, 2025

Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders have earned a 99% return over the last year
RIGL

Simply Wall St.

18 days ago

Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders have earned a 99% return over the last year

Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now?
RIGL

Zacks

a month ago

Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now?

Wall Street Analysts See a 71.97% Upside in Rigel (RIGL): Can the Stock Really Move This High?
RIGL

Zacks

a month ago

Wall Street Analysts See a 71.97% Upside in Rigel (RIGL): Can the Stock Really Move This High?

Rigel to Present at the Jefferies Global Healthcare Conference
RIGL

PR Newswire

a month ago

Rigel to Present at the Jefferies Global Healthcare Conference

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress
RIGL

PR Newswire

2 months ago

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress

Here's Why Rigel (RIGL) Is a Great 'Buy the Bottom' Stock Now
RIGL

Zacks

2 months ago

Here's Why Rigel (RIGL) Is a Great 'Buy the Bottom' Stock Now

Is Rigel Pharmaceuticals (RIGL) a Great Value Stock Right Now?
RIGL

Zacks

2 months ago

Is Rigel Pharmaceuticals (RIGL) a Great Value Stock Right Now?

Upgrade: Analysts Just Made A Captivating Increase To Their Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Forecasts
RIGL

Simply Wall St.

2 months ago

Upgrade: Analysts Just Made A Captivating Increase To Their Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Forecasts

Biotech Alert: Searches spiking for these stocks today
RIGL

TipRanks

2 months ago

Biotech Alert: Searches spiking for these stocks today

Earnings Estimates Rising for Rigel (RIGL): Will It Gain?
RIGL

Zacks

2 months ago

Earnings Estimates Rising for Rigel (RIGL): Will It Gain?

Rigel Pharmaceuticals, Inc. Just Recorded A 370% EPS Beat: Here's What Analysts Are Forecasting Next
RIGL

Simply Wall St.

2 months ago

Rigel Pharmaceuticals, Inc. Just Recorded A 370% EPS Beat: Here's What Analysts Are Forecasting Next

Wall Street Analysts Think Rigel (RIGL) Could Surge 82.3%: Read This Before Placing a Bet
RIGL

Zacks

2 months ago

Wall Street Analysts Think Rigel (RIGL) Could Surge 82.3%: Read This Before Placing a Bet

Rigel Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations
RIGL

Simply Wall St.

2 months ago

Rigel Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations

Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...
RIGL

GuruFocus.com

2 months ago

Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Rigel Pharmaceuticals (RIGL) Beats Q1 Earnings and Revenue Estimates
RIGL

Zacks

2 months ago

Rigel Pharmaceuticals (RIGL) Beats Q1 Earnings and Revenue Estimates

Rigel Reports First Quarter 2025 Financial Results and Provides Business Update
RIGL

PR Newswire

2 months ago

Rigel Reports First Quarter 2025 Financial Results and Provides Business Update

Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Report Preview: What To Expect
RIGL

GuruFocus.com

2 months ago

Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Report Preview: What To Expect

Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update
RIGL

PR Newswire

2 months ago

Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update

Rigel (RIGL) Upgraded to Buy: What Does It Mean for the Stock?
RIGL

Zacks

3 months ago

Rigel (RIGL) Upgraded to Buy: What Does It Mean for the Stock?

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
RIGL

PR Newswire

3 months ago

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

High Growth Tech Stocks in the US for April 2025
RIGL

Simply Wall St.

3 months ago

High Growth Tech Stocks in the US for April 2025

RIGL

MT Newswires

3 months ago

Rigel Pharmaceuticals Settles Patent Litigation Over Tavalisse

Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent Litigation
RIGL

PR Newswire

3 months ago

Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent Litigation

Statutory Profit Doesn't Reflect How Good Rigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are
RIGL

Simply Wall St.

4 months ago

Statutory Profit Doesn't Reflect How Good Rigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are

Rigel Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations
RIGL

Simply Wall St.

4 months ago

Rigel Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations

Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors
RIGL

PR Newswire

4 months ago

Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors

Rigel Pharmaceuticals, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
RIGL

Simply Wall St.

4 months ago

Rigel Pharmaceuticals, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

RIGL

Thomson Reuters StreetEvents

4 months ago

Q4 2024 Rigel Pharmaceuticals Inc Earnings Call

Wall Street Analysts Believe Rigel (RIGL) Could Rally 44.93%: Here's is How to Trade
RIGL

Zacks

4 months ago

Wall Street Analysts Believe Rigel (RIGL) Could Rally 44.93%: Here's is How to Trade

RIGL

MT Newswires

4 months ago

B. Riley Raises Price Target on Rigel Pharmaceuticals to $24 From $20, Keeps Neutral Rating

Rigel Pharmaceuticals Inc (RIGL) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...
RIGL

GuruFocus.com

4 months ago

Rigel Pharmaceuticals Inc (RIGL) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...

Rigel Pharmaceuticals (RIGL) Surpasses Q4 Earnings and Revenue Estimates
RIGL

Zacks

4 months ago

Rigel Pharmaceuticals (RIGL) Surpasses Q4 Earnings and Revenue Estimates

RIGL

Associated Press Finance

4 months ago

Rigel: Q4 Earnings Snapshot

Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
RIGL

PR Newswire

4 months ago

Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Rigel Pharmaceuticals Inc (RIGL) Q4 2024: Everything You Need To Know Ahead Of Earnings
RIGL

GuruFocus.com

4 months ago

Rigel Pharmaceuticals Inc (RIGL) Q4 2024: Everything You Need To Know Ahead Of Earnings

Sea Limited to Post Q4 Earnings: What's in Store for the Stock?
RIGL

Zacks

4 months ago

Sea Limited to Post Q4 Earnings: What's in Store for the Stock?

High Growth Tech Stocks In The US Market To Watch
RIGL

Simply Wall St.

4 months ago

High Growth Tech Stocks In The US Market To Watch

Should You Add RIGL Stock to Your Portfolio Pre-Q4 Earnings?
RIGL

Zacks

4 months ago

Should You Add RIGL Stock to Your Portfolio Pre-Q4 Earnings?

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update
RIGL

PR Newswire

4 months ago

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update

RIGL Stock Surges 41.4% in a Year: Time to Buy or Sell?
RIGL

Zacks

5 months ago

RIGL Stock Surges 41.4% in a Year: Time to Buy or Sell?

With 57% ownership of the shares, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is heavily dominated by institutional owners
RIGL

Simply Wall St.

5 months ago

With 57% ownership of the shares, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is heavily dominated by institutional owners

Does Rigel (RIGL) Have the Potential to Rally 40.88% as Wall Street Analysts Expect?
RIGL

Zacks

5 months ago

Does Rigel (RIGL) Have the Potential to Rally 40.88% as Wall Street Analysts Expect?

Rigel enrols first subject in Phase I sickle cell disease therapy trial
RIGL

Clinical Trials Arena

6 months ago

Rigel enrols first subject in Phase I sickle cell disease therapy trial

RIGL

MT Newswires

6 months ago

Rigel Pharmaceuticals Says First Patient Enrolled in Study of Fostamatinib to Treat Sickle Cell Disease

Rigel's Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease
RIGL

PR Newswire

6 months ago

Rigel's Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease

Wall Street Analysts Predict a 75.79% Upside in Rigel (RIGL): Here's What You Should Know
RIGL

Zacks

6 months ago

Wall Street Analysts Predict a 75.79% Upside in Rigel (RIGL): Here's What You Should Know

Best Momentum Stock to Buy for January 17th
RIGL

Zacks

6 months ago

Best Momentum Stock to Buy for January 17th

Rigel (RIGL) Upgraded to Buy: Here's Why
RIGL

Zacks

6 months ago

Rigel (RIGL) Upgraded to Buy: Here's Why

Exploring Three High Growth Tech Stocks In The United States
RIGL

Simply Wall St.

6 months ago

Exploring Three High Growth Tech Stocks In The United States

RIGL

MT Newswires

6 months ago

Rigel Pharmaceuticals Expects Higher Q4 Revenue, Provides 2025 Revenue Guidance

Rigel Provides Business Update and 2025 Outlook
RIGL

PR Newswire

6 months ago

Rigel Provides Business Update and 2025 Outlook

RIGL

MT Newswires

6 months ago

Rigel Pharmaceuticals Says Potential Myelodysplastic Syndromes Therapy Gets FDA Orphan Drug Status

Small-Cap Stocks Can Outperform Large-Cap Peers in 2025: 5 Top Picks
RIGL

Zacks

6 months ago

Small-Cap Stocks Can Outperform Large-Cap Peers in 2025: 5 Top Picks

Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS
RIGL

PR Newswire

6 months ago

Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS

Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference
RIGL

PR Newswire

6 months ago

Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
RIGL

PR Newswire

6 months ago

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Recent 26% pullback isn't enough to hurt long-term Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders, they're still up 50% over 1 year
RIGL

Simply Wall St.

7 months ago

Recent 26% pullback isn't enough to hurt long-term Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders, they're still up 50% over 1 year

RIGL

MT Newswires

7 months ago

Rigel Pharmaceuticals Reports Initial Efficacy, Safety Data from Cancer Drug Study

Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition
RIGL

PR Newswire

7 months ago

Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition

RIGL

MT Newswires

7 months ago

B. Riley Adjusts Price Target on Rigel Pharmaceuticals to $27 From $17, Maintains Neutral Rating

RIGL

MT Newswires

7 months ago

Rigel Pharmaceuticals Says its R289 Hematology Drug Candidate Receives Fast-Track Designation From US FDA

Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
RIGL

PR Newswire

7 months ago

Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS

How Much Upside is Left in Rigel (RIGL)? Wall Street Analysts Think 28.28%
RIGL

Zacks

8 months ago

How Much Upside is Left in Rigel (RIGL)? Wall Street Analysts Think 28.28%

Zacks.com featured highlights Rigel, Synchrony Financial, SkyWest, Allient and Rush Street Interactive
RIGL

Zacks

8 months ago

Zacks.com featured highlights Rigel, Synchrony Financial, SkyWest, Allient and Rush Street Interactive

5 Relative Price Strength Options Available for Investors
RIGL

Zacks

8 months ago

5 Relative Price Strength Options Available for Investors

Exploring Three High Growth Tech Stocks in the United States
RIGL

Simply Wall St.

8 months ago

Exploring Three High Growth Tech Stocks in the United States

Rigel to Present at the Jefferies London Healthcare Conference
RIGL

PR Newswire

8 months ago

Rigel to Present at the Jefferies London Healthcare Conference

Rigel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
RIGL

Simply Wall St.

8 months ago

Rigel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

RIGL

Thomson Reuters StreetEvents

8 months ago

Q3 2024 Rigel Pharmaceuticals Inc Earnings Call

Rigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...
RIGL

GuruFocus.com

8 months ago

Rigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...

Rigel Pharmaceuticals (RIGL) Q3 Earnings and Revenues Top Estimates
RIGL

Zacks

8 months ago

Rigel Pharmaceuticals (RIGL) Q3 Earnings and Revenues Top Estimates

RIGL

Associated Press Finance

8 months ago

Rigel: Q3 Earnings Snapshot

Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update
RIGL

PR Newswire

8 months ago

Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update

Rigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Report Preview: What To Expect
RIGL

GuruFocus.com

8 months ago

Rigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Report Preview: What To Expect

Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and Exposition
RIGL

PR Newswire

8 months ago

Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and Exposition

Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business Update
RIGL

PR Newswire

8 months ago

Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business Update

Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO® (pralsetinib)
RIGL

PR Newswire

8 months ago

Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO® (pralsetinib)

RIGL

MT Newswires

9 months ago

Optime Care Expands Partnership with Rigel Pharmaceuticals

Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®
RIGL

GlobeNewswire

9 months ago

Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
RIGL

PR Newswire

9 months ago

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

High Growth Tech Stocks in the United States to Watch
RIGL

Simply Wall St.

9 months ago

High Growth Tech Stocks in the United States to Watch

Rigel (RIGL) Surges 19.7%: Is This an Indication of Further Gains?
RIGL

Zacks

9 months ago

Rigel (RIGL) Surges 19.7%: Is This an Indication of Further Gains?

Rigel to Present at the 2024 Cantor Global Healthcare Conference
RIGL

PR Newswire

10 months ago

Rigel to Present at the 2024 Cantor Global Healthcare Conference

Rigel enrols first participant in Phase Ib/II AML treatment regimen trial
RIGL

Clinical Trials Arena

10 months ago

Rigel enrols first participant in Phase Ib/II AML treatment regimen trial

Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA® (olutasidenib) in mIDH1 AML
RIGL

PR Newswire

10 months ago

Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA® (olutasidenib) in mIDH1 AML

Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and Taiwan
RIGL

PR Newswire

10 months ago

Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and Taiwan

With 45% stake, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) seems to have captured institutional investors' interest
RIGL

Simply Wall St.

10 months ago

With 45% stake, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) seems to have captured institutional investors' interest

Rigel to Participate in Upcoming September Investor Conferences
RIGL

PR Newswire

10 months ago

Rigel to Participate in Upcoming September Investor Conferences

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Analysts Are Pretty Bullish On The Stock After Recent Results
RIGL

Simply Wall St.

a year ago

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Analysts Are Pretty Bullish On The Stock After Recent Results

RIGL

Thomson Reuters StreetEvents

a year ago

Q2 2024 Rigel Pharmaceuticals Inc Earnings Call

Rigel Pharmaceuticals (RIGL) Reports Q2 Loss, Tops Revenue Estimates
RIGL

Zacks

a year ago

Rigel Pharmaceuticals (RIGL) Reports Q2 Loss, Tops Revenue Estimates

RIGL

Associated Press Finance

a year ago

Rigel: Q2 Earnings Snapshot

Rigel Reports Second Quarter 2024 Financial Results and Provides Business Update
RIGL

PR Newswire

a year ago

Rigel Reports Second Quarter 2024 Financial Results and Provides Business Update

Profound Medical (PROF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
RIGL

Zacks

a year ago

Profound Medical (PROF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Collegium Pharmaceutical (COLL) Soars 10.6%: Is Further Upside Left in the Stock?
RIGL

Zacks

a year ago

Collegium Pharmaceutical (COLL) Soars 10.6%: Is Further Upside Left in the Stock?

Rigel Pharmaceuticals (RIGL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
RIGL

Zacks

a year ago

Rigel Pharmaceuticals (RIGL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Rigel Announces Conference Call and Webcast to Report Second Quarter 2024 Financial Results and Business Update
RIGL

PR Newswire

a year ago

Rigel Announces Conference Call and Webcast to Report Second Quarter 2024 Financial Results and Business Update

Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Intrinsic Value Is Potentially 87% Above Its Share Price
RIGL

Simply Wall St.

a year ago

Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Intrinsic Value Is Potentially 87% Above Its Share Price

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
RIGL

PR Newswire

a year ago

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL): Are Analysts Optimistic?
RIGL

Simply Wall St.

a year ago

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL): Are Analysts Optimistic?

Share on Social Networks: